The Chemical Companies responsible for Agent Orange and Genetically Modified Seeds continue their bid to merge into mega monopolies. The merger between Dow and DuPont is almost a year in the making, as it was announced in late 2015. Recently, Monsanto Corp. announced it was being purchased by Bayer. Both Dow and Monsanto were contracted by the D.O.D to manufacture the chemical herbicide Agent Orange. Agent Orange is responsible for killing and sicking those exposed. It is strongly suspected to have caused birth defects and ailments in the offspring of those exposed.
November 15, 2016
Dow Chemical Co. and DuPont Co. are expecting to get formal objections to their $60 billion merger from European Union regulators as soon as next month, listing potential antitrust concerns with their bid to form the world’s biggest chemical company, according to two people familiar with the investigation.
The European Commission in Brussels is poised to send the complaint to the companies in December, according to people who asked not to be named because the process is confidential. It may lay out how the transaction could reduce competition in areas such as crop protection, seeds and certain petrochemicals.
The merger is among a trio of pending deals — including Bayer AG’s agreement to buy Monsanto Co. and China National Chemical Corp.’s agreement to buy Syngenta AG — that could reshape the agricultural-chemicals industry. EU Competition Commissioner Margrethe Vestager has warned that the deals could leave the sector “quite concentrated.”
“I think we are looking at a process where Dow-DuPont is in much more trouble than the other two deals,” said Alan Riley, senior fellow at the Institute for Statecraft, a London-based think tank. “They are both funding R&D in the same fields so there is a real issue of innovation loss from the deal” that might be difficult to eliminate with guarantees to regulators promising good behavior.
Dow-DuPont was the first to get an extended probe by the EU and now has a Feb. 28 deadline for a final decision. Regulators last month also opened a longer investigation of China National Chemical’s bid for Switzerland’s Syngenta. Bayer is yet to file for EU approval to buy Monsanto.